This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Alcon (ALC) Gets a Buy from RBC Capital

Tipranks - Fri May 8, 1:16AM CDT

RBC Capital analyst Jack Reynolds-Clark maintained a Buy rating on Alcon yesterday and set a price target of CHF80.00.

Claim 55% Off TipRanks

According to TipRanks, Reynolds-Clark is a 2-star analyst with an average return of 0.3% and a 37.50% success rate. Reynolds-Clark covers the Healthcare sector, focusing on stocks such as Alcon, ConvaTec, and Smith & Nephew.

In addition to RBC Capital, Alcon also received a Buy from Needham’s David Saxon in a report issued yesterday. However, on the same day, Barclays reiterated a Hold rating on Alcon (NYSE: ALC).

Based on Alcon’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of CHF2.74 billion and a net profit of CHF218.77 million. In comparison, last year the company earned a revenue of CHF2.5 billion and had a net profit of CHF284 million

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.